Regulation of Met1-linked polyubiquitin signalling by the deubiquitinase OTULIN

FEBS Journal

Volumn 283, Issue 1, 2016, Pages 39-53

  Elliott, Paul R ^a   Komander, David ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

deubiquitinase; LUBAC; Met1 linked; NF B; OTULIN; signalling; substrate assisted catalysis; ubiquitin

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; DEUBIQUITINASE; GLUTAMIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LINEAR UBIQUITIN CHAIN ASSEMBLY COMPLEX; MET1 LINKED POLYUBIQUITIN; OTULIN PROTEIN; POLYUBIQUITIN; PROTEIN P97; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; DNA (CYTOSINE 5) METHYLTRANSFERASE; GUMBY PROTEIN, HUMAN; PROTEINASE;

BINDING SITE; CATALYSIS; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ENZYME ACTIVE SITE; ENZYME SPECIFICITY; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN HYDROLYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; UBIQUITINATION; WNT SIGNALING PATHWAY; ANIMAL; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; ENDOPEPTIDASES; HUMANS; POLYUBIQUITIN; SIGNAL TRANSDUCTION;

EID: 84957729036     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.13547     Document Type: Review

References (99)

1. Hershko A, &, Ciechanover A, (1998) The ubiquitin system. Annu Rev Biochem 67, 425-479.
2. Komander D, &, Rape M, (2012) The ubiquitin code. Annu Rev Biochem 81, 203-229.
3. Kerscher O, Felberbaum R, &, Hochstrasser M, (2006) Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu Rev Cell Dev Biol 22, 159-180.
4. Husnjak K, &, Dikic I, (2012) Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions. Annu Rev Biochem 81, 291-322.
5. Clague MJ, Barsukov I, Coulson JM, Liu H, Rigden DJ, &, Urbé S, (2013) Deubiquitylases from genes to organism. Physiol Rev 93, 1289-1315.
6. Clague MJ, Heride C, &, Urbé S, (2015) The demographics of the ubiquitin system. Trends Cell Biol 25, 417-426.
7. Kulathu Y, &, Komander D, (2012) Atypical ubiquitylation-the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages. Nat Rev Mol Cell Biol 13, 508-523.
8. Behrends C, &, Harper JW, (2011) Constructing and decoding unconventional ubiquitin chains. Nat Struct Mol Biol 18, 520-528.
9. Kirisako T, Kamei K, Murata S, Kato M, Fukumoto H, Kanie M, Sano S, Tokunaga F, Tanaka K, &, Iwai K, (2006) A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J 25, 4877-4887.
10. Tokunaga F, &, Iwai K, (2012) LUBAC, a novel ubiquitin ligase for linear ubiquitination, is crucial for inflammation and immune responses. Microbes Infect 14, 563-572.
11. Wenzel DM, Lissounov A, Brzovic PS, &, Klevit RE, (2011) UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids. Nature 474, 105-108.
12. Smit JJ, Monteferrario D, Noordermeer SM, van Dijk WJ, van der Reijden BA, &, Sixma TK, (2012) The E3 ligase HOIP specifies linear ubiquitin chain assembly through its RING-IBR-RING domain and the unique LDD extension. EMBO J 31, 3833-3844.
13. Stieglitz B, Morris-Davies AC, Koliopoulos MG, Christodoulou E, &, Rittinger K, (2012) LUBAC synthesizes linear ubiquitin chains via a thioester intermediate. EMBO Rep 13, 840-846.
14. Stieglitz B, Rana RR, Koliopoulos MG, Morris-Davies AC, Schaeffer V, Christodoulou E, Howell S, Brown NR, Dikic I, &, Rittinger K, (2013) Structural basis for ligase-specific conjugation of linear ubiquitin chains by HOIP. Nature 503, 422-426.
15. Rahighi S, Ikeda F, Kawasaki M, Akutsu M, Suzuki N, Kato R, Kensche T, Uejima T, Bloor S, Komander D, et al,. (2009) Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation. Cell 136, 1098-1109.
16. Komander D, Reyes-Turcu F, Licchesi JDF, Odenwaelder P, Wilkinson KD, &, Barford D, (2009) Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. EMBO Rep 10, 466-473.
17. Verhelst K, Carpentier I, Kreike M, Meloni L, Verstrepen L, Kensche T, Dikic I, &, Beyaert R, (2012) A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7. EMBO J 31, 3845-3855.
18. Tokunaga F, Nishimasu H, Ishitani R, Goto E, Noguchi T, Mio K, Kamei K, Ma A, Iwai K, &, Nureki O, (2012) Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation. EMBO J 31, 3856-3870.
19. Sato Y, Fujita H, Yoshikawa A, Yamashita M, Yamagata A, Kaiser SE, Iwai K, &, Fukai S, (2011) Specific recognition of linear ubiquitin chains by the Npl4 zinc finger (NZF) domain of the HOIL-1L subunit of the linear ubiquitin chain assembly complex. Proc Natl Acad Sci 108, 20520-20525.
20. Tokunaga F, Sakata S-I, Saeki Y, Satomi Y, Kirisako T, Kamei K, Nakagawa T, Kato M, Murata S, Yamaoka S, et al,. (2009) Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat Cell Biol 11, 123-132.
21. Haas TL, Emmerich CH, Gerlach B, Schmukle AC, Cordier SM, Rieser E, Feltham R, Vince J, Warnken U, Wenger T, et al,. (2009) Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol Cell 36, 831-844.
22. Gerlach B, Cordier SM, Schmukle AC, Emmerich CH, Rieser E, Haas TL, Webb AI, Rickard JA, Anderton H, Wong WW-L, et al,. (2011) Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471, 591-596.
23. Tokunaga F, Nakagawa T, Nakahara M, Saeki Y, Taniguchi M, Sakata S-I, Tanaka K, Nakano H, &, Iwai K, (2011) SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex. Nature 471, 633-636.
24. Ikeda F, Deribe YL, Skånland SS, Stieglitz B, Grabbe C, Franz-Wachtel M, van Wijk SJL, Goswami P, Nagy V, Terzic J, et al,. (2011) SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature 471, 637-641.
25. Boisson B, Laplantine E, Prando C, Giliani S, Israelsson E, Xu Z, Abhyankar A, Israël L, Trevejo-Nunez G, Bogunovic D, et al,. (2012) Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat Immunol 13, 1178-1186.
26. Boisson B, Laplantine E, Dobbs K, Cobat A, Tarantino N, Hazen M, Lidov HGW, Hopkins G, Du L, Belkadi A, et al,. (2015) Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J Exp Med 212, 939-951.
27. Iwai K, Fujita H, &, Sasaki Y, (2014) Linear ubiquitin chains: NF-κB signalling, cell death and beyond. Nat Rev Mol Cell Biol 15, 503-508.
28. Fiil BK, &, Gyrd-Hansen M, (2014) Met1-linked ubiquitination in immune signalling. FEBS J 281, 4337-4350.
29. Keusekotten K, Elliott PR, Glockner L, Fiil BK, Damgaard RB, Kulathu Y, Wauer T, Hospenthal MK, Gyrd-Hansen M, Krappmann D, et al,. (2013) OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin. Cell 153, 1312-1326.
30. Rivkin E, Almeida SM, Ceccarelli DF, Juang Y-C, MacLean TA, Srikumar T, Huang H, Dunham WH, Fukumura R, Xie G, et al,. (2013) The linear ubiquitin-specific deubiquitinase gumby regulates angiogenesis. Nature 498, 318-324.
31. Ye Y, Blaser G, Horrocks MH, Ruedas-Rama MJ, Ibrahim S, Zhukov AA, Orte A, Klenerman D, Jackson SE, &, Komander D, (2012) Ubiquitin chain conformation regulates recognition and activity of interacting proteins. Nature 492, 266-270.
32. Varadan R, Assfalg M, Haririnia A, Raasi S, Pickart C, &, Fushman D, (2004) Solution conformation of Lys63-linked di-ubiquitin chain provides clues to functional diversity of polyubiquitin signaling. J Biol Chem 279, 7055-7063.
33. Kulathu Y, Akutsu M, Bremm A, Hofmann K, &, Komander D, (2009) Two-sided ubiquitin binding explains specificity of the TAB 2 NZF domain. Nat Struct Mol Biol 16, 1328-1330.
34. Faesen AC, Luna-Vargas MPA, Geurink PP, Clerici M, Merkx R, van Dijk WJ, Hameed DS, El Oualid F, Ovaa H, &, Sixma TK, (2011) The differential modulation of USP activity by internal regulatory domains, interactors and eight ubiquitin chain types. Chem Biol 18, 1550-1561.
35. Ritorto MS, Ewan R, Perez-Oliva AB, Knebel A, Buhrlage SJ, Wightman M, Kelly SM, Wood NT, Virdee S, Gray NS, et al,. (2014) Screening of DUB activity and specificity by MALDI-TOF mass spectrometry. Nat Commun 5, 4763.
36. Mevissen TET, Hospenthal MK, Geurink PP, Elliott PR, Akutsu M, Arnaudo N, Ekkebus R, Kulathu Y, Wauer T, El Oualid F, et al,. (2013) OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis. Cell 154, 169-184.
37. Komander D, Lord CJ, Scheel H, Swift S, Hofmann K, Ashworth A, &, Barford D, (2008) The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box module. Mol Cell 29, 451-464.
38. Sato Y, Goto E, Shibata Y, Kubota Y, Yamagata A, Goto-Ito S, Kubota K, Inoue J-I, Takekawa M, Fukai S, et al,. (2015) Structures of CYLD USP with Met1- or Lys63-linked diubiquitin reveal mechanisms for dual specificity. Nat Struct Mol Biol, 22, 222-229.
39. Mar L, Rivkin E, Kim DY, Yu JY, &, Cordes SP, (2005) A genetic screen for mutations that affect cranial nerve development in the mouse. J Neurosci 25, 11787-11795.
40. Rawlings ND, Waller M, Barrett AJ, &, Bateman A, (2014) MEROPS: the database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res 42, D503-D509.
41. Hu M, Li P, Li M, Li W, Yao T, Wu J-W, Gu W, Cohen RE, &, Shi Y, (2002) Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 111, 1041-1054.
42. Edelmann MJ, Iphöfer A, Akutsu M, Altun M, di Gleria K, Kramer HB, Fiebiger E, Dhe-Paganon S, &, Kessler BM, (2009) Structural basis and specificity of human otubain 1-mediated deubiquitination. Biochem J 418, 379-390.
43. Wiener R, Zhang X, Wang T, &, Wolberger C, (2012) The mechanism of OTUB1-mediated inhibition of ubiquitination. Nature 483, 618-622.
44. Borodovsky A, Ovaa H, Kolli N, Gan-Erdene T, Wilkinson KD, Ploegh HL, &, Kessler BM, (2002) Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. Chem Biol 9, 1149-1159.
45. Wickliffe KE, Lorenz S, Wemmer DE, Kuriyan J, &, Rape M, (2011) The mechanism of linkage-specific ubiquitin chain elongation by a single-subunit E2. Cell 144, 769-781.
46. Scott DC, Sviderskiy VO, Monda JK, Lydeard JR, Cho SE, Harper JW, &, Schulman BA, (2014) Structure of a RING E3 trapped in action reveals ligation mechanism for the ubiquitin-like protein NEDD8. Cell 157, 1671-1684.
47. Kulathu Y, Garcia FJ, Mevissen TET, Busch M, Arnaudo N, Carroll KS, Barford D, &, Komander D, (2013) Regulation of A20 and other OTU deubiquitinases by reversible oxidation. Nat Commun 4, 1569.
48. Cotto-Rios XM, Békés M, Chapman J, Ueberheide B, &, Huang TT, (2012) Deubiquitinases as a signaling target of oxidative stress. Cell Rep 2, 1475-1484.
49. Lee J-G, Baek K, Soetandyo N, &, Ye Y, (2013) Reversible inactivation of deubiquitinases by reactive oxygen species in vitro and in cells. Nat Commun 4, 1568.
50. Enesa K, Ito K, Luong LA, Thorbjornsen I, Phua C, To Y, Dean J, Haskard DO, Boyle J, Adcock I, et al,. (2008) Hydrogen peroxide prolongs nuclear localization of NF-kappaB in activated cells by suppressing negative regulatory mechanisms. J Biol Chem 283, 18582-18590.
51. Matsumoto ML, Dong KC, Yu C, Phu L, Gao X, Hannoush RN, Hymowitz SG, Kirkpatrick DS, Dixit VM, &, Kelley RF, (2012) Engineering and structural characterization of a linear polyubiquitin-specific antibody. J Mol Biol 418, 134-144.
52. Walczak H, Iwai K, &, Dikic I, (2012) Generation and physiological roles of linear ubiquitin chains. BMC Biol 10, 23.
53. Hayden MS, &, Ghosh S, (2004) Signaling to NF-kappaB. Genes Dev 18, 2195-2224.
54. Bonizzi G, &, Karin M, (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25, 280-288.
55. Vallabhapurapu S, &, Karin M, (2009) Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 27, 693-733.
56. Hayden MS, &, Ghosh S, (2012) NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev 26, 203-234.
57. Emmerich CH, Ordureau A, Strickson S, Arthur JSC, Pedrioli PGA, Komander D, &, Cohen P, (2013) Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains. Proc Natl Acad Sci 110, 15247-15252.
58. McCullough J, Clague MJ, &, Urbé S, (2004) AMSH is an endosome-associated ubiquitin isopeptidase. J Cell Biol 166, 487-492.
59. Hospenthal MK, Mevissen TET, &, Komander D, (2015) Deubiquitinase-based analysis of ubiquitin chain architecture using Ubiquitin Chain Restriction (UbiCRest). Nat Protoc 10, 349-361.
60. Schaeffer V, Akutsu M, Olma MH, Gomes LC, Kawasaki M, &, Dikic I, (2014) Binding of OTULIN to the PUB domain of HOIP controls NF-κB signaling. Mol Cell 54, 349-361.
61. Philpott DJ, Sorbara MT, Robertson SJ, Croitoru K, &, Girardin SE, (2014) NOD proteins: regulators of inflammation in health and disease. Nat Rev Immunol 14, 9-23.
62. Damgaard RB, Nachbur U, Yabal M, Wong WW-L, Fiil BK, Kastirr M, Rieser E, Rickard JA, Bankovacki A, Peschel C, et al,. (2012) The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. Mol Cell 46, 746-758.
63. Damgaard RB, Fiil BK, Speckmann C, Yabal M, Stadt UZ, Bekker-Jensen S, Jost PJ, Ehl S, Mailand N, &, Gyrd-Hansen M, (2013) Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling. EMBO Mol Med 5, 1278-1295.
64. Fiil BK, Damgaard RB, Wagner SA, Keusekotten K, Fritsch M, Bekker-Jensen S, Mailand N, Choudhary C, Komander D, &, Gyrd-Hansen M, (2013) OTULIN restricts Met1-Linked ubiquitination to control innate immune signaling. Mol Cell 50, 818-830.
65. Yagi H, Ishimoto K, Hiromoto T, Fujita H, Mizushima T, Uekusa Y, Yagi-Utsumi M, Kurimoto E, Noda M, Uchiyama S, et al,. (2012) A non-canonical UBA-UBL interaction forms the linear-ubiquitin-chain assembly complex. EMBO Rep 13, 462-468.
66. Fujita H, Rahighi S, Akita M, Kato R, Sasaki Y, Wakatsuki S, &, Iwai K, (2014) Mechanism underlying IκB Kinase activation mediated by the linear ubiquitin chain assembly complex. Mol Cell Biol 34, 1322-1335.
67. Meyer H, Bug M, &, Bremer S, (2012) Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system. Nat Cell Biol 14, 117-123.
68. Allen MD, Buchberger A, &, Bycroft M, (2006) The PUB domain functions as a p97 binding module in human peptide N-glycanase. J Biol Chem 281, 25502-25508.
69. Zhao G, Zhou X, Wang L, Li G, Schindelin H, &, Lennarz WJ, (2007) Studies on peptide:N-glycanase-p97 interaction suggest that p97 phosphorylation modulates endoplasmic reticulum-associated degradation. Proc Natl Acad Sci USA 104, 8785-8790.
70. Madsen L, Seeger M, Semple CA, &, Hartmann-Petersen R, (2009) New ATPase regulators-p97 goes to the PUB. Int J Biochem Cell Biol 41, 2380-2388.
71. Elliott PR, Nielsen SV, Marco-Casanova P, Fiil BK, Keusekotten K, Mailand N, Freund SMV, Gyrd-Hansen M, &, Komander D, (2014) Molecular basis and regulation of OTULIN-LUBAC interaction. Mol Cell 54, 335-348.
72. Takiuchi T, Nakagawa T, Tamiya H, Fujita H, Sasaki Y, Saeki Y, Takeda H, Sawasaki T, Buchberger A, Kimura T, et al,. (2014) Suppression of LUBAC-mediated linear ubiquitination by a specific interaction between LUBAC and the deubiquitinases CYLD and OTULIN. Genes Cells 19, 254-272.
73. Li JM, Wu H, Zhang W, Blackburn MR, &, Jin J, (2014) The p97-UFD1L-NPL4 protein complex mediates cytokine-induced I&kgr;Bα proteolysis. Mol Cell Biol 34, 335-347.
74. Sowa ME, Bennett EJ, Gygi SP, &, Harper JW, (2009) Defining the human deubiquitinating enzyme interaction landscape. Cell 138, 389-403.
75. Li M, Brooks CL, Kon N, &, Gu W, (2004) A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol Cell 13, 879-886.
76. Hayes SD, Liu H, MacDonald E, Sanderson CM, Coulson JM, Clague MJ, &, Urbé S, (2012) Direct and indirect control of mitogen-activated protein kinase pathway-associated components, BRAP/IMP E3 ubiquitin ligase and CRAF/RAF1 kinase, by the deubiquitylating enzyme USP15. J Biol Chem 287, 43007-43018.
77. Nakamura N, Harada K, Kato M, &, Hirose S, (2014) Ubiquitin-specific protease 19 regulates the stability of the E3 ubiquitin ligase MARCH6. Exp Cell Res 328, 207-216.
78. Zou Q, Jin J, Hu H, Li HS, Romano S, Xiao Y, Nakaya M, Zhou X, Cheng X, Yang P, et al,. (2014) USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses. Nat Immunol 15, 562-570.
79. Yuan J, Luo K, Deng M, Li Y, Yin P, Gao B, Fang Y, Wu P, Liu T, &, Lou Z, (2014) HERC2-USP20 axis regulates DNA damage checkpoint through Claspin. Nucleic Acids Res 42, 13110-13121.
80. Scaglione KM, Zavodszky E, Todi SV, Patury S, Xu P, Rodríguez-Lebrón E, Fischer S, Konen J, Djarmati A, Peng J, et al,. (2011) Ube2w and ataxin-3 coordinately regulate the ubiquitin ligase CHIP. Mol Cell 43, 599-612.
81. Hymowitz SG, &, Wertz IE, (2010) A20: from ubiquitin editing to tumour suppression. Nat Rev Cancer 10, 332-341.
82. Catrysse L, Vereecke L, Beyaert R, &, van Loo G, (2014) A20 in inflammation and autoimmunity. Trends Immunol 35, 22-31.
83. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, Wu P, Wiesmann C, Baker R, Boone DL, et al,. (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430, 694-699.
84. Shembade N, Parvatiyar K, Harhaj NS, &, Harhaj EW, (2009) The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling. EMBO J 28, 513-522.
85. Shembade N, Ma A, &, Harhaj EW, (2010) Inhibition of NF-{kappa}B signaling by A20 through disruption of ubiquitin enzyme complexes. Science 327, 1135-1139.
86. Lu TT, Onizawa M, Hammer GE, Turer EE, Yin Q, Damko E, Agelidis A, Shifrin N, Advincula R, Barrera J, et al,. (2013) Dimerization and ubiquitin mediated recruitment of A20, a complex deubiquitinating enzyme. Immunity 38, 896-905.
87. De A, Dainichi T, Rathinam CV, &, Ghosh S, (2014) The deubiquitinase activity of A20 is dispensable for NF-κB signaling. EMBO Rep 15, 775-783.
88. Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R, Green H, Brown C, Biggs PJ, Lakhani SR, et al,. (2000) Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 25, 160-165.
89. Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, &, Mosialos G, (2003) CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424, 793-796.
90. Brummelkamp TR, Nijman SMB, Dirac AMG, &, Bernards R, (2003) Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424, 797-801.
91. Kovalenko A, Chable-Bessia C, Cantarella G, Israël A, Wallach D, &, Courtois G, (2003) The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 424, 801-805.
92. Sun S-C, (2010) CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes. Cell Death Differ 17, 25-34.
93. Pannu J, Belle JI, Forster M, Duerr CU, Shen S, Kane L, Harcourt K, Fritz JH, Clare S, &, Nijnik A, (2015) Ubiquitin specific protease 21 is dispensable for normal development, hematopoiesis and lymphocyte differentiation. PLoS One 10, e0117304.
94. Xiao N, Li H, Luo J, Wang R, Chen H, Chen J, &, Wang P, (2012) Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration. Biochem J 441, 979-986.
95. Colleran A, Collins PE, O'Carroll C, Ahmed A, Mao X, McManus B, Kiely PA, Burstein E, &, Carmody RJ, (2013) Deubiquitination of NF-κB by Ubiquitin-Specific Protease-7 promotes transcription. Proc Natl Acad Sci 110, 618-623.
96. Xu G, Tan X, Wang H, Sun W, Shi Y, Burlingame S, Gu X, Cao G, Zhang T, Qin J, et al,. (2010) Ubiquitin-specific peptidase 21 inhibits tumor necrosis factor alpha-induced nuclear factor kappaB activation via binding to and deubiquitinating receptor-interacting protein 1. J Biol Chem 285, 969-978.
97. Tauriello DVF, Haegebarth A, Kuper I, Edelmann MJ, Henraat M, Canninga-van Dijk MR, Kessler BM, Clevers H, &, Maurice MM, (2010) Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl. Mol Cell 37, 607-619.
98. Peltzer N, Rieser E, Taraborrelli L, Draber P, Darding M, Pernaute B, Shimizu Y, Sarr A, Draberova H, Montinaro A, et al,. (2014) HOIP deficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death. Cell Rep 9, 153-165.
99. Mannherz O, Mertens D, Hahn M, &, Lichter P, (2006) Functional screening for proapoptotic genes by reverse transfection cell array technology. Genomics 87, 665-672.